CompletedPhase 3NCT02993510
A Randomized Controlled Trial Comparing Chondro-Gide® to Microfracture Alone for Treatment of Knee Cartilage Defects.
Studying Osteochondrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Geistlich Pharma AG
- Principal Investigator
- Sven Anders, MD, M.DUniversity of Regensburg
- Intervention
- Microfracture(procedure)
- Enrollment
- 67 enrolled
- Eligibility
- 18-50 years · All sexes
- Timeline
- 2003 – 2016
Study locations (7)
- University of Regensburg, Bad Abbach, Germany
- Universitätsklinikum Freiburg, Freiburg im Breisgau, Germany
- Universitätsklinikum Giessen, Giessen, Germany
- Orthopedikum Hamburg, Hamburg, Germany
- Unfallklinik Hannover, Hanover, Germany
- University of Schleswig-Holstein, Lübeck, Germany
- Sportklinik Ravensburg, Ravensburg, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02993510 on ClinicalTrials.govOther trials for Osteochondrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06462040Evaluation of Clinical and Radiological Outcomes in Patients Undergoing Fixation of Osteochondral Fragments With Reasorbable Screws in the Knee JointIstituto Ortopedico Rizzoli
- RECRUITINGNCT04364334Knee Registry (Knieregister)UMC Utrecht
- ACTIVE NOT RECRUITINGNCT02771496Osteochondritis Dissecans of Knee Prospective CohortUniversity of Pennsylvania